Actinomycin D for fibrosis management in ophthalmic implant surgery
Implants that feature a drug delivery system loaded with antifibrotic active drugs provide a promising approach to address postoperative complications caused by fibrosis. This study is intended to clarify whether Actinomycin D has an impact specifically on components of the extracellular matrix (ECM...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
De Gruyter
2019-09-01
|
| Rangatū: | Current Directions in Biomedical Engineering |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1515/cdbme-2019-0121 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|